Investigating that increase, Thakar says the team found that as anti-rejection medicines and the ability to deliver complex care has improved, they saw a trend of older transplant recipients with an increased
comorbid disease burden.
Not exact matches
The authors interpret this data to suggest one of the factors that may be associated with the increasing trend of AKI is the
comorbid and chronic
disease burden and severity of illness at the time patients receive heart or liver transplants.